Michael Peled

Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor

Michael Peled, Anna S. Tocheva, Sabina Sandigursky et al. · Proceedings of the National Academy of Sciences · 2017 · 88 citations · Full text

Pd-1 Uncovers Sap, Immunology, Molecular Biology +19

A wild-type mouse-based model for the regression of inflammation in atherosclerosis

Michael Peled, Hitoo Nishi, Ada Weinstock et al. · PLoS ONE · 2017 · 54 citations · Full text

Vascular Disease, Immunology, Hyperlipidemia +19

<p>Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients</p>

Valentina Magri, Teodor Gottfried, Mattia Di Segni et al. · Cancer Management and Research · 2019 · 48 citations · Full text

Neoadjuvant pembrolizumab (Pembro) for early stage non-small cell lung cancer (NSCLC): Updated report of a phase I study, MK3475-223.

Jair Bar, Damien Urban, Efrat Ofek et al. · Journal of Clinical Oncology · 2019 · 40 citations

Surgical Oncology, Early Stage Nsclc, Medicine +15

Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis

Michael Peled, Marianne Strazza, Inbar Azoulay‐Alfaguter · Inflammation · 2015 · 35 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +8